company background image
MDC logo

Medlab Clinical ASX:MDC Stock Report

Last Price

AU$6.60

Market Cap

AU$15.1m

7D

0%

1Y

-43.6%

Updated

22 May, 2023

Data

Company Financials +

This company listing is no longer active

This company may still be operating, however this listing is no longer active. Find out why through their latest events.

Medlab Clinical Limited Competitors

Price History & Performance

Summary of all time highs, changes and price drops for Medlab Clinical
Historical stock prices
Current Share PriceAU$6.60
52 Week HighAU$14.94
52 Week LowAU$6.45
Beta1.1
1 Month Change0%
3 Month Change-4.21%
1 Year Change-43.59%
3 Year Change-79.05%
5 Year Change-91.85%
Change since IPO-78.00%

Recent News & Updates

Recent updates

Shareholders May Be More Conservative With Medlab Clinical Limited's (ASX:MDC) CEO Compensation For Now

Oct 06
Shareholders May Be More Conservative With Medlab Clinical Limited's (ASX:MDC) CEO Compensation For Now

Is Medlab Clinical (ASX:MDC) In A Good Position To Invest In Growth?

Oct 05
Is Medlab Clinical (ASX:MDC) In A Good Position To Invest In Growth?

What We Learned About Medlab Clinical's (ASX:MDC) CEO Pay

Feb 21
What We Learned About Medlab Clinical's (ASX:MDC) CEO Pay

Medlab Clinical (ASX:MDC) Share Prices Have Dropped 69% In The Last Three Years

Dec 30
Medlab Clinical (ASX:MDC) Share Prices Have Dropped 69% In The Last Three Years

Medlab Clinical Limited (ASX:MDC) Is Expected To Breakeven In The Near Future

Nov 22
Medlab Clinical Limited (ASX:MDC) Is Expected To Breakeven In The Near Future

Shareholder Returns

MDCAU BiotechsAU Market
7D0%-0.2%-1.7%
1Y-43.6%4.9%7.0%

Return vs Industry: MDC underperformed the Australian Biotechs industry which returned 11.4% over the past year.

Return vs Market: MDC underperformed the Australian Market which returned -1.5% over the past year.

Price Volatility

Is MDC's price volatile compared to industry and market?
MDC volatility
MDC Average Weekly Movementn/a
Biotechs Industry Average Movement10.8%
Market Average Movement8.7%
10% most volatile stocks in AU Market16.4%
10% least volatile stocks in AU Market3.2%

Stable Share Price: MDC has not had significant price volatility in the past 3 months.

Volatility Over Time: Insufficient data to determine MDC's volatility change over the past year.

About the Company

FoundedEmployeesCEOWebsite
2012n/aSean Hallwww.medlab.co

Medlab Clinical Limited, a biotechnology company, researches, develops, and pre-commercializes pharmaceutical and nutraceutical products in Australia. Its drug candidate includes NanaBis, a buccal spray from cannabis oil extract for oncology and pain management; and NanoCBD, a buccal spray from hemp oil extract for mental health. The company also develops NanoCelle, a patented sub-micron drug delivery platform that allows passive diffusion of active pharmaceutical ingredients directly into the bloodstream through oral-buccal, sublingual, intranasal, and transdermal or topical delivery.

Medlab Clinical Limited Fundamentals Summary

How do Medlab Clinical's earnings and revenue compare to its market cap?
MDC fundamental statistics
Market capAU$15.07m
Earnings (TTM)-AU$8.32m
Revenue (TTM)AU$1.54m

9.8x

P/S Ratio

-1.8x

P/E Ratio

Earnings & Revenue

Key profitability statistics from the latest earnings report (TTM)
MDC income statement (TTM)
RevenueAU$1.54m
Cost of RevenueAU$336.29k
Gross ProfitAU$1.20m
Other ExpensesAU$9.52m
Earnings-AU$8.32m

Last Reported Earnings

Jun 30, 2022

Next Earnings Date

n/a

Earnings per share (EPS)-3.64
Gross Margin78.11%
Net Profit Margin-541.67%
Debt/Equity Ratio0%

How did MDC perform over the long term?

See historical performance and comparison
Simply Wall Street Pty Ltd (ACN 600 056 611), is a Corporate Authorised Representative (Authorised Representative Number: 467183) of Sanlam Private Wealth Pty Ltd (AFSL No. 337927). Any advice contained in this website is general advice only and has been prepared without considering your objectives, financial situation or needs. You should not rely on any advice and/or information contained in this website and before making any investment decision we recommend that you consider whether it is appropriate for your situation and seek appropriate financial, taxation and legal advice. Please read our Financial Services Guide before deciding whether to obtain financial services from us.